Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amnesia01:13

Amnesia

101
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
101
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Dissociative Amnesia01:21

Dissociative Amnesia

41
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
41
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

523
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
523

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of <i>Clostridium difficile</i> Infection in Patients With Idiopathic Pulmonary Fibrosis: Analysis of the Nationwide Inpatient Sample, 2016-2020.

JGH open : an open access journal of gastroenterology and hepatology·2026
Same author

Comparison of Crotalidae Immune F(ab')2 (Equine) and Crotalidae Polyvalent Immune Fab (Ovine) at Establishing Control of Initial Envenomation Symptoms in Louisiana Agkistrodon Envenomations.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2025
Same author

Metal Pneumonitis from "Non-toxic" Decorative Cake Dust Aspiration: A Case Report.

Clinical practice and cases in emergency medicine·2024
Same author

Saving Hearts in Rural West Texas: The Impact of Critical Care Access on Mortality Rates.

Cureus·2024
Same author

Warfarin induced spontaneous gastric intramural haematoma presenting with palpitations.

BMJ case reports·2024
Same author

Effect of osteopathic manipulative treatment and Bio-Electro-Magnetic Energy Regulation (BEMER) therapy on generalized musculoskeletal neck pain in adults.

Journal of osteopathic medicine·2023

Related Experiment Video

Updated: Jun 6, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K

Transient global amnesia predisposed by rizatriptan and temazepam.

Taylor Sanders1, Chun Ho Szeto2, Divya Parepalli2

  • 1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA taylor.sanders@ttuhsc.edu.

BMJ Case Reports
|November 28, 2024
PubMed
Summary

Transient global amnesia (TGA) can occur after taking migraine and insomnia medications. This case highlights the importance of distinguishing TGA from stroke to avoid unnecessary treatments.

Keywords:
Memory DisordersNeurology (drugs and medicines)Unwanted effects / adverse reactions

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

28.5K

Related Experiment Videos

Last Updated: Jun 6, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.2K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.8K
Controlled Cortical Impact Model for Traumatic Brain Injury
05:30

Controlled Cortical Impact Model for Traumatic Brain Injury

Published on: August 5, 2014

28.5K

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Transient global amnesia (TGA) is a neurological disorder characterized by acute anterograde amnesia, typically resolving within 24 hours.
  • Differential diagnosis of TGA is crucial, requiring exclusion of cerebrovascular events like transient ischemic attack (TIA) and stroke.

Observation:

  • A woman in her 60s presented with acute memory loss and confusion after using rizatriptan for migraine and temazepam for insomnia.
  • Initial management considered acute ischemic stroke, with tissue plasminogen activator administered.

Findings:

  • A comprehensive neurological evaluation led to a diagnosis of TGA after ruling out other causes.
  • The case suggests a potential link between the combined use of triptans and benzodiazepines and the precipitation of TGA.

Implications:

  • This case underscores the importance of considering medication interactions, specifically triptans and benzodiazepines, as potential triggers for TGA.
  • Accurate differentiation of TGA from cerebrovascular diseases is vital to prevent inappropriate thrombolytic therapy and reduce healthcare costs.